Supporting the

Neuroendocrine Cancer Community

Cervical Screening

Feb 14, 2022

Around 2,700 women, in England alone, are diagnosed with cervical cancer each year and it is the second most common cancer amongst women under 35.

Early diagnosis is essential to ensure early treatment and reduce the number of cervical cancer related deaths – currently 2 a day.

Across the UK, women and people with a cervix aged 25-64, are regularly invited to attend cervical screening : you can book an appointment with your GP practice if you missed your last screening date. 

Neuroendocrine Cancers of the female reproductive organs (ovaries, womb, cervix, vagina and vulva) range from the uncommon to incredibly rare, depending on site of origin.

Neuroendocrine Cancer of the Ovary affects approximately 30 women a year in the UK.

Primary Neuroendocrine Cancers of the cervix and womb are even rarer: 

Neuroendocrine carcinomas of the cervix account for less than 2% of all invasive cervical cancers and are classified as low-grade (carcinoid, atypical carcinoid tumour) or high-grade (known as small- and large-cell) neuroendocrine carcinomas. 

BUT RARE doesn’t mean NEVER

Don’t ignore your cervical screening invite 

If you already have another form of cancer – this doesn’t reduce your risk of cervical cancer – screening matters.

Talk to you GP or clinical team if you have any concerns!



To find out more: